zika
viru
zikv
outbreak
link
microcephali
trigger
public
health
concern
examin
antibodi
respons
patient
infect
zikv
use
singlecel
pcr
clone
heavi
light
chainpair
monoclon
antibodi
mab
bind
zikv
envelop
e
protein
isol
memori
b
cell
zikvinfect
patient
three
mab
show
potent
broad
neutral
activ
african
asian
american
strain
select
analysi
mab
show
valu
ngml
circul
american
strain
epitop
map
reveal
mab
target
residu
later
ridg
lr
epitop
ediii
domain
broader
lr
epitop
footprint
recogn
residu
well
mab
recogn
residu
edii
domain
interestingli
although
patient
seroneg
denv
infect
mab
origin
germlin
pair
neutral
zikv
administr
mab
protect
neonat
scid
mice
infect
lethal
dose
zikv
studi
provid
potenti
therapeut
antibodi
candid
insight
antibodi
respons
zikv
infect
zika
viru
zikv
member
flavivirida
famili
includ
dengu
viru
denv
japanes
enceph
viru
jev
yellow
fever
viru
yfv
west
nile
viru
wnv
tickborn
enceph
viru
tbev
zikv
mainli
transmit
aed
mosquito
also
spread
sexual
contact
blood
transfus
via
mothertochild
transmiss
pregnanc
zikv
first
discov
africa
confin
within
equatori
zone
africa
asia
outbreak
yap
island
transmit
french
polynesia
southern
pacif
island
believ
adapt
infect
zikv
mosquitovector
contribut
spread
viru
asia
america
zikv
outbreak
associ
increas
microcephali
case
brazil
increas
global
awar
date
countri
report
zikv
infect
known
zikv
cross
placent
barrier
lead
fetal
microcephali
caus
neurolog
complic
adult
syndrom
current
approv
drug
vaccin
mitig
risk
zikv
infect
zikv
surfac
form
copi
envelop
e
glycoprotein
associ
membran
protein
e
protein
arrang
dimer
three
parallel
dimer
connect
form
raft
raft
cover
viral
surfac
e
protein
mediat
viral
entri
host
cell
membran
fusion
major
target
neutral
antibodi
vaccin
immunogen
flaviviru
e
ectodomain
consist
three
distinct
domain
edi
betabarrel
act
bridg
edii
ediii
edii
fingerlik
structur
respons
dimer
solubl
e
protein
monom
viral
fusion
ediii
immunoglobulinlik
segment
involv
host
cell
receptor
recognit
viral
fusion
recent
year
number
neutral
antibodi
nab
isol
individu
infect
zikv
nab
mainli
recogn
edii
ediii
tertiari
quaternari
epitop
constitut
e
ectodomain
although
ediiitarget
antibodi
repres
rel
small
popul
e
proteinbind
antibodi
presenc
associ
serum
neutral
activ
zikv
among
nab
ediiitarget
antibodi
ediiedim
epitop
ede
target
antibodi
show
potent
neutral
activ
studi
clone
character
etarget
monoclon
antibodi
mab
chines
patient
return
china
visit
venezuela
select
mab
evalu
neutral
activ
vitro
vivo
via
zikvinfect
neonat
sever
combin
immunodefici
scid
mous
model
patient
male
return
venezuela
februari
hospit
guangzhou
peopl
hospit
guangzhou
china
zikv
rna
detect
serum
saliva
urin
sampl
rtpcr
patient
manifest
rel
mild
symptom
includ
fever
rash
sore
throat
fatigu
recov
discharg
approxim
week
onset
symptom
detect
zikv
patient
test
serolog
neg
infect
use
elisa
kit
euroimmun
lubeck
germani
indic
patient
previou
exposur
infect
zikv
singl
b
cell
sort
rtpcr
sequenc
clone
freshli
isol
peripher
blood
mononuclear
cell
pbmc
stain
cocktail
antibodi
includ
antihuman
invitrogen
carlsbad
ca
bd
bioscienc
franklin
lake
nj
antihisp
miltenyi
biotec
bergisch
gladbach
germani
antigenspecif
memori
b
cell
use
zikv
e
protein
cat
sino
biolog
inc
beij
china
probe
wash
igg
memori
b
cell
sort
use
multilas
ariaii
sorter
individu
b
cell
sort
pcr
plate
contain
lysi
buffer
per
cell
lysi
buffer
contain
rnasin
inhibitor
promega
madison
wi
firststrand
buffer
dtt
igep
sigmaaldrich
st
loui
mo
pcr
plate
sort
cell
frozen
dri
ice
store
subject
revers
transcript
rtpcr
clone
express
vector
perform
previous
describ
briefli
random
hexam
promega
dntp
mm
superscript
iii
invitrogen
ad
well
follow
incub
h
igg
heavi
light
chain
variabl
region
amplifi
independ
nest
pcr
first
round
pcr
perform
use
cdna
directli
follow
revers
transcript
hotstart
taq
plu
dna
polymeras
qiagen
hilden
germani
primer
mix
pcr
programm
initi
min
incub
follow
cycl
first
round
second
round
min
follow
min
cool
use
agaros
gel
pcr
product
evalu
excis
gel
approxim
bp
heavi
chain
bp
kappa
lambda
chain
sent
sanger
sequenc
purif
human
antibodi
sequenc
analys
use
imgtvquest
http
wwwimgtorg
fulllength
express
cotransfect
cell
equal
amount
pair
heavi
light
chain
plasmid
base
backbon
pcineo
vector
cultur
media
harvest
four
day
transfect
purifi
use
protein
agaros
ge
healthcar
chicago
il
zikv
particl
success
isol
infect
patient
blood
plasma
urin
viru
passag
suckl
mous
brain
cultur
vero
cell
prepar
stock
store
use
hawaii
strain
new
guineac
strain
strain
strain
prepar
vero
cell
recombin
zikv
e
ediii
protein
cat
respect
purchas
sino
biolog
inc
e
protein
deriv
zikv
strain
isol
brazil
ediii
protein
cat
ediii
protein
cat
e
protein
cat
also
purchas
sino
biolog
inc
nunc
maxisorp
plate
thermo
fisher
scientif
waltham
coat
zikv
e
e
domain
iii
protein
incub
overnight
block
h
plate
wash
six
time
phosphatebuff
salin
pb
transfect
antibodi
supernat
dilut
block
buffer
serial
dilut
purifi
mab
secondari
antibodi
goat
antihuman
igg
abcam
cambridg
uk
appli
dilut
block
solut
plate
incub
room
temperatur
h
tmb
substrat
absorb
valu
determin
nm
use
biotek
plate
reader
biotek
instrument
winooski
vt
neutral
activ
purifi
antibodi
measur
use
flow
cytometrybas
neutral
assay
vero
cell
previous
report
minor
modif
briefli
cell
plate
plate
h
experi
purifi
human
mab
serial
dilut
dmem
gibco
thermo
fisher
scientif
supplement
feta
bovin
serum
fb
gibco
incub
zikv
pfu
h
co
cell
incub
mixtur
h
co
mlwell
mem
medium
contain
fb
ad
incub
anoth
h
zikvinfect
uninfect
cell
use
posit
neg
control
respect
cell
trypsin
fix
permeabilis
fixat
permeabil
solut
bd
bioscienc
ice
min
follow
stain
antibodi
dilut
permwash
buffer
stain
antimous
igg
fitc
permwash
buffer
ice
min
wash
percentag
eposit
cell
measur
use
bd
facscanto
ii
bd
bioscienc
antibodi
dilut
neutral
virus
halfmaxim
neutral
inhibitori
concentr
calcul
nonlinear
doserespons
regress
analysi
graphpad
prism
version
graphpad
softwar
inc
la
jolla
ca
epitop
map
perform
shotgun
mutagenesi
previous
describ
zikv
prme
protein
express
construct
base
zikv
strain
subject
highthroughput
alanin
scan
mutagenesi
gener
comprehens
mutat
librari
residu
within
prme
chang
alanin
alanin
codon
mutat
serin
total
zikv
prme
mutant
gener
coverag
confirm
sequencingand
array
plate
zikv
prme
mutant
transfect
cell
incub
h
cell
fix
vv
paraformaldehyd
electron
microscopi
scienc
hatfield
pa
permeabilis
wv
saponin
sigmaaldrich
pb
plu
calcium
magnesium
pb
map
cell
sequenti
incub
mab
alexafluor
secondari
antibodi
jackson
immunoresearch
laboratori
west
grove
pa
dilut
pb
normal
goat
serum
sigmaaldrich
saponin
cell
wash
three
time
saponin
twice
pb
mean
cellular
fluoresc
record
use
highthroughput
flow
cytomet
htfc
intellicyt
albuquerqu
nm
antibodi
reactiv
prme
mutant
rel
wildtyp
wt
protein
calcul
subtract
signal
mocktransfect
control
normal
signal
wt
prmetransfect
control
bind
competit
mab
five
ediiitarget
antibodi
determin
use
realtim
labelfre
biolay
interferometri
assay
octet
biosensor
fortebio
fremont
ca
previous
describ
experi
perform
pb
buffer
shake
rpm
ninta
biosensor
fortebio
first
load
histagged
protein
associ
first
mab
irrelev
mab
use
neg
control
pb
use
blank
solut
biosensor
dip
second
mab
incub
presenc
first
mab
capac
addit
bind
monitor
measur
shift
mab
evalu
concentr
nm
except
nm
nm
nm
satur
measur
ninta
biosensor
regener
mm
glycinehcl
ph
ge
healthcar
recharg
mm
nicl
respons
mab
bind
e
protein
compar
data
process
use
biaevalu
softwar
biacor
uppsala
sweden
use
pregnant
scid
suckl
mice
studi
carri
strict
complianc
associ
assess
accredit
laboratori
anim
care
experiment
protocol
approv
guangzhou
institut
biomedicin
health
gibh
institut
anim
care
use
committe
scid
beig
mice
purchas
beij
vital
river
laboratori
anim
technolog
co
ltd
beij
china
onedayold
suckl
mice
n
intraperiton
inocul
zikv
pfu
zikv
mab
administ
singl
dose
h
viru
infect
mous
brain
spleen
serum
sampl
collect
day
viru
infect
rna
extract
qiagen
zikv
rna
detect
determin
onestep
qrtpcr
qiagen
realtim
pcr
system
biorad
laboratori
hercul
ca
use
publish
primer
condit
briefli
rna
togeth
mixtur
sybr
green
rtmix
forward
revers
primer
place
pcr
plate
reaction
volum
amplif
perform
min
min
follow
cycl
viral
load
express
scale
viral
rna
copi
per
comparison
standard
curv
three
replic
conduct
sampl
flow
cytometr
data
analys
use
flowjo
version
tree
star
inc
ashland
halfmaxim
effect
bind
concentr
valu
obtain
elisa
assay
zikv
eediii
bind
activ
mab
neutral
assay
respect
calcul
use
doserespons
inhibit
model
sigmoid
curv
gener
use
graphpad
prism
version
graphpad
softwar
inc
statist
signific
differ
viral
load
group
determin
use
oneway
anova
p
valu
consid
statist
signific
clone
etarget
mab
zikvinfect
patient
use
recombin
zikv
e
protein
probe
isol
especif
memori
b
cell
chines
patient
return
venezuela
identifi
infect
zikv
border
entri
thirtyon
mab
bind
e
protein
success
clone
day
onset
symptom
first
use
facsbas
neutral
assay
screen
neutral
activ
cultur
media
cell
transfect
express
plasmid
heavi
light
chain
mab
eight
mab
best
neutral
activ
bind
e
protein
select
analysi
bind
activ
eight
mab
zikv
e
ediii
denvi
ediii
protein
assess
figur
tabl
mab
bound
zikv
e
ediii
mab
bound
e
protein
ediii
figur
mab
show
strong
bind
activ
zikv
e
ediii
protein
nanomolar
rang
measur
neutral
activ
purifi
mab
zikv
strain
zikv
genom
sequenc
current
circul
zikv
strain
south
america
zikv
strain
isol
patient
three
mab
show
best
neutral
activ
valu
ngml
respect
thu
analys
mab
epitop
identif
anim
model
figur
b
also
test
neutral
activ
three
mab
two
zikv
isol
first
zikv
isol
zika
forest
uganda
zikv
isol
puerto
rico
three
antibodi
crossneutr
tabl
intriguingli
one
mab
show
bind
ediii
protein
denv
ediii
protein
denv
ediii
ngml
compar
zikv
ediii
bind
ngml
measur
neutral
activ
three
repres
mab
found
mab
show
denvi
ediii
crossreact
fail
neutral
denvi
viru
wherea
show
potent
neutral
activ
tabl
neutral
mab
recogn
either
ediii
edii
later
ridg
lr
ediii
recogn
major
target
site
nab
bind
differ
epitop
region
use
biolay
interferometri
bli
competit
assay
probe
whether
etarget
mab
bind
epitop
region
histag
e
protein
captur
ninta
biosensor
first
satur
one
mab
competit
bind
second
mab
assess
bind
competit
mab
five
zikv
etarget
mab
measur
figur
mab
could
block
bind
mab
e
protein
indic
five
mab
share
overlap
epitop
zikv
ediii
interestingli
mab
bind
e
protein
block
mab
etarget
mab
indic
may
bind
broader
epitop
footprint
ediii
wherea
bind
smaller
epitop
region
overlap
bind
region
next
map
detail
epitop
residu
mab
use
shotgun
alaninescan
mutagenesi
librari
zikv
prm
e
protein
variant
mab
recogn
epitop
region
includ
residu
along
lr
region
ediii
notabl
mab
recogn
lr
region
key
residu
figur
b
c
amino
acid
sequenc
align
e
protein
zikv
denv
reveal
residu
zikv
e
protein
correspond
present
e
protein
figur
mab
ediitarget
antibodi
recogn
residu
edii
confirm
individu
mutat
key
residu
reduc
bind
activ
compar
wt
prme
protein
figur
b
analysi
immunoglobulin
heavi
chain
reveal
deriv
germlin
respect
figur
shm
rate
heavi
chain
compar
predict
germlin
sequenc
rel
low
lower
antibodi
isol
annual
trival
inactiv
influenza
vaccin
tiv
donor
chronic
human
immunodefici
viru
hiv
patient
compar
germlin
sequenc
shm
region
wherea
shm
found
sporad
region
tabl
pair
heavi
chain
predict
germlin
hgl
light
chain
kappa
k
similarli
pair
k
express
heavi
chain
germlinerevert
antibodi
cell
germlinerevert
antibodi
show
reduc
bind
activ
e
protein
time
lower
matur
almost
complet
lost
bind
abil
compar
matur
tabl
therefor
shm
necessari
strong
bind
e
protein
low
level
shm
need
improv
bind
evalu
protect
effect
etarget
mab
develop
zikv
lethal
infect
mous
model
intraperiton
infect
scid
neonat
pfu
zikv
caus
lethal
within
day
neonat
mice
receiv
treatment
show
diseas
symptom
includ
ruffl
fur
trembl
shake
bodi
weight
loss
figur
neonat
mice
treat
mab
either
h
infect
surviv
lethal
infect
figur
b
titrat
viral
load
brain
spleen
collect
day
infect
reveal
dosedepend
decreas
viral
rna
mice
treat
mab
wherea
mice
receiv
treatment
much
higher
viral
rna
level
brain
spleen
figur
c
treatment
mab
result
best
protect
detect
viral
rna
brain
spleen
also
demonstr
subsequ
experi
zikvinfect
neonat
scid
mice
surviv
exhibit
weight
loss
treatment
either
mab
figur
e
f
separ
experi
unrel
mab
specif
influenza
viru
show
protect
effect
zikvinfect
neonat
scid
mice
data
shown
therefor
ediiitarget
ediitarget
mab
effect
protect
neonat
scid
mice
lethal
zikv
infect
emerg
zikv
south
america
rais
global
health
concern
due
link
zikv
infect
microcephali
infant
syndrom
adult
search
develop
vaccin
therapeut
prevent
control
zikv
infect
thu
necessari
exampl
nab
found
effect
combat
emerg
virus
middl
east
respiratori
syndrom
coronaviru
merscov
ebola
viru
influenza
viru
present
studi
clone
zikv
e
proteinbind
mab
memori
b
cell
zikvinfect
chines
patient
select
three
mab
studi
character
zikv
e
protein
epitop
recogn
mab
analys
shm
pattern
two
potent
mab
ediiitarget
show
neutral
activ
three
differ
zikv
strain
includ
south
american
circul
strain
african
strain
american
strain
mab
recogn
sever
residu
lr
region
ediii
individu
mutat
residu
led
decreas
bind
activ
compar
wt
prme
protein
previou
studi
also
demonstr
k
mutat
alon
abolish
neutral
activ
lrtarget
mab
meanwhil
heavi
light
chain
mab
deriv
germlin
respect
report
zikv
mab
pair
antibodi
present
five
six
peopl
sequenti
infect
zikv
thu
mab
determin
recurr
antibodi
recogn
zikv
virus
find
along
observ
studi
suggest
may
preferenti
enlist
respons
zikv
denv
infect
interest
note
mab
recogn
lr
region
zikv
ediii
mab
report
other
also
recogn
zikv
ediii
ediii
although
mab
neutral
african
zikv
strain
anoth
report
mab
also
recogn
zikv
e
protein
neutral
strain
fail
neutral
strain
differ
may
current
zikv
strain
possess
ediii
region
wherea
african
strain
ediii
region
therefor
lr
region
ediii
appear
key
target
residu
ediiitarget
antibodi
exert
neutral
activ
mab
recogn
show
potent
vitro
neutral
activ
support
notion
residu
hotspot
effect
neutral
activ
ediiitarget
mab
import
note
report
etarget
neutral
mab
ediiitarget
wherea
neutral
mab
ediitarget
mab
show
broad
neutral
activ
flavivirus
report
recogn
edii
target
either
fusion
loop
epitop
fle
ede
region
antibodi
target
fle
conserv
among
flavivirus
bind
zikv
e
protein
report
fletarget
antibodi
show
poor
neutral
activ
strong
infect
enhanc
vitro
meanwhil
antibodi
target
ede
show
potent
neutral
activ
zikv
protect
zikv
infect
mous
rhesu
macaqu
model
notabl
mab
studi
show
potent
neutral
activ
three
test
zikv
strain
like
ediitarget
mab
also
recogn
residu
similar
report
edetarget
antibodi
recogn
mab
recogn
two
residu
edii
region
structur
analysi
indic
mab
crosslink
e
monom
within
dimer
neighbour
dimer
zikv
particl
therefor
mab
may
exhibit
interact
viru
particl
recent
anoth
edetarget
mab
report
neutral
multipl
zikv
strain
recogn
residu
edii
region
mab
recogn
residu
notabl
mab
isol
memori
b
cell
zikv
tabl
amino
acid
sequenc
correspond
vh
germlin
sequenc
predict
sequenc
convalesc
patient
possibl
residu
hotspot
edetarget
neutral
antibodi
futur
structur
biolog
analysi
requir
confirm
mab
inde
edetarget
antibodi
antigenspecif
b
cell
undergo
process
term
shm
increas
antigen
affin
interestingli
neutral
mab
rel
low
shm
rate
vh
gene
much
lower
antibodi
isol
annual
tiv
vaccin
donor
chronic
patient
possibl
person
expos
zikv
infect
etarget
antibodi
requir
low
shm
rate
bind
neutral
zikv
gener
even
rel
low
shm
rate
limit
mutat
appear
essenti
confer
bind
activ
mab
heavi
chain
revert
predict
germlin
sequenc
pair
respect
matur
light
chain
bind
activ
zikv
e
protein
found
almost
complet
impair
time
lower
matur
respect
therefor
viral
load
spleen
n
total
rna
extract
homogen
brain
spleen
zikv
genom
rna
evalu
use
onestep
qpcr
viral
load
express
genom
copi
number
per
microgram
tissu
e
bodi
weight
chang
zikvinfect
mice
treat
mab
f
surviv
curv
zikvinfect
mice
treat
mab
data
repres
two
independ
experi
present
mean
sem
p
p
p
ns
signific
oneway
anova
mutat
suffici
necessari
confer
neutral
activ
zikv
infect
addit
evalu
neutral
activ
repres
mab
inhibit
zikv
infect
cultur
cell
also
test
protect
efficaci
mab
neonat
scid
mous
model
zikv
infect
wt
mice
result
diseas
wherea
suckl
wt
mice
suscept
infect
mice
lack
interferon
signal
type
ifnar
ko
interferon
regulatori
factor
irf
tripl
ko
type
ifn
ko
suscept
zikv
infect
detect
zikv
brain
spinal
cord
test
mice
die
within
day
postinfect
studi
develop
scid
beig
suckl
mous
model
evalu
protect
abil
mab
zikv
infect
scid
beig
mice
defici
b
nk
cell
thu
suitabl
evalu
net
effect
antizikv
mab
zikv
infect
scid
beig
suckl
mice
led
neurolog
symptom
high
viral
load
brain
spleen
eventu
lethal
three
mab
test
ediiitarget
mab
ediitarget
mab
show
protect
effect
zikvinfect
scid
mice
therefor
nab
zikv
clone
convalesc
patient
potenti
develop
treat
zikv
infect
opinion
etarget
mab
may
mediat
antibodydepend
enhanc
ade
viru
infect
found
mab
enhanc
zikv
infect
cell
low
concentr
ngml
howev
believ
ade
critic
concern
concentr
mab
use
treatment
much
higher
nevertheless
engin
mab
fc
fragment
minim
fc
gamma
receptormedi
infect
would
benefici
improv
practic
usag
neutral
mab
overal
studi
find
provid
insight
antibodi
respons
zikv
infect
demonstr
potenti
mab
zikv
treatment
